PMWC 2022 Silicon Valley

Ann Klein

Immunotherapy Track Track Chair: Ira Mellman, Genentech Human cells have been successfully used as treatment for blood cancers for decades but translating the promise to cell-based treatment for solid tumors has been slow. The advent of gene-editing techniques such as CRISPR, coupled with advances in our understanding of immunology and optimization of growing, manufacturing, transporting, storing, and handling specialized biological samples and materials is transforming the cell therapy field. We will hear in this session about some of the most promising work in the field, as well as the challenges in overcoming resistance Session: Next-generation Supply Chain For Cell & Gene Therapies (PANEL) Session Chair: Sharon Benzeno, Adaptive Biotechnologies - Ann Klein, Vineti - Tim Moore, Pact Pharma - Heidi Hunter, Cardinal Health